ID27545A - Penggunaan turunan taksoid baru - Google Patents

Penggunaan turunan taksoid baru

Info

Publication number: ID27545A
Authority: ID; Indonesia
Prior art keywords: deposit; taxoid; formula; new taxoid; new
Prior art date: 1998-08-17

Application number

IDW20010379A

Other languages

English (en)

Indonesian (id)

Inventor

Mary-Christine Bissery

Patricia Vrignaud

Simon Roberts

Clive Brealey

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-17

Filing date

1999-08-13

Publication date

2001-04-12

1998-08-17 Priority claimed from EP98115401A external-priority patent/EP0982027A1/en

1999-08-13 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2001-04-12 Publication of ID27545A publication Critical patent/ID27545A/id

Links

UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
230000002159 abnormal effect Effects 0.000 abstract 1
210000004556 brain Anatomy 0.000 abstract 1
230000004663 cell proliferation Effects 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IDW20010379A 1998-08-17 1999-08-13 Penggunaan turunan taksoid baru ID27545A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98115401A EP0982027A1 (en)	1998-08-17	1998-08-17	Taxoid derivatives for treating abnormal cell proliferation of the brain
US9958198P	1998-09-08	1998-09-08

Publications (1)

Publication Number	Publication Date
ID27545A true ID27545A (id)	2001-04-12

Family

ID=26149540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010379A ID27545A (id)	1998-08-17	1999-08-13	Penggunaan turunan taksoid baru

Country Status (19)

Country	Link
US (1)	US6346543B1 (sr)
EP (1)	EP1109547A1 (sr)
JP (1)	JP5354762B2 (sr)
KR (1)	KR100710533B1 (sr)
AU (1)	AU766168B2 (sr)
BG (1)	BG65365B1 (sr)
CA (1)	CA2340921C (sr)
CZ (1)	CZ293959B6 (sr)
EE (1)	EE04903B1 (sr)
HU (1)	HU230235B1 (sr)
ID (1)	ID27545A (sr)
IL (1)	IL141238A0 (sr)
ME (1)	ME00533B (sr)
NO (1)	NO327296B1 (sr)
NZ (1)	NZ509965A (sr)
RS (1)	RS52011B (sr)
SK (1)	SK285212B6 (sr)
TR (1)	TR200100557T2 (sr)
WO (1)	WO2000009120A1 (sr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr) *	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1020188A1 (en) *	1999-01-13	2000-07-19	Aventis Pharma S.A.	New use of taxoid derivatives
EP1274720A4 (en) *	2000-04-12	2004-08-18	Human Genome Sciences Inc	FUSION PROTEINS CONTAINING ALBUMIN
WO2002097038A2 (en) *	2001-05-25	2002-12-05	Human Genome Sciences, Inc.	Chemokine beta-1 fusion proteins
PT1463751E (pt)	2001-12-21	2013-08-26	Human Genome Sciences Inc	Proteínas de fusão de albumina
EP1463752A4 (en) *	2001-12-21	2005-07-13	Human Genome Sciences Inc	ALBUM INFUSION PROTEINS
CA2513213C (en)	2003-01-22	2013-07-30	Human Genome Sciences, Inc.	Albumin fusion proteins
FR2859996B1 (fr) *	2003-09-19	2006-02-03	Aventis Pharma Sa	Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr)	2008-01-17	2009-07-24	Aventis Pharma Sa	Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
US8637466B2 (en)	2008-08-11	2014-01-28	Nektar Therapeutics	Multi-arm polymeric alkanoate conjugates
EP2493466B1 (en)	2009-10-29	2021-03-10	Sanofi Mature IP	Novel antitumoral use of cabazitaxel
US10894087B2 (en)	2010-12-22	2021-01-19	Nektar Therapeutics	Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en)	2010-12-22	2013-12-12	Nektar Therapeutics	Multi-arm polymeric prodrug conjugates of taxane-based compounds
EP2791122B1 (en)	2011-12-13	2019-01-23	Aventis Pharma S.A.	Crystalline form of cabazitaxel and process for preparing the same
NZ628565A (en) *	2012-02-10	2016-03-31	Aventis Pharma Sa	New pediatric uses of cabazitaxel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9102128A (es) *	1990-11-23	1992-07-08	Rhone Poulenc Rorer Sa	Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696459B1 (fr)	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé de préparation de dérivés du taxane.
TW467896B (en)	1993-03-19	2001-12-11	Bristol Myers Squibb Co	Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
MA23823A1 (fr) *	1995-03-27	1996-10-01	Aventis Pharma Sa	Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) *	1995-03-27	1998-12-08	Rhone-Poulenc Rorer, S.A.	Taxoids, their preparation and pharmaceutical compositions containing them
US5481018A (en)	1995-03-31	1996-01-02	The Dow Chemical Company	Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2771092B1 (fr)	1997-11-18	1999-12-17	Rhone Poulenc Rorer Sa	Procede de preparation de derives de la classe des taxoides

1999
- 1999-08-11 US US09/371,838 patent/US6346543B1/en not_active Expired - Lifetime
- 1999-08-13 TR TR2001/00557T patent/TR200100557T2/xx unknown
- 1999-08-13 AU AU57419/99A patent/AU766168B2/en not_active Expired
- 1999-08-13 RS YU7901A patent/RS52011B/sr unknown
- 1999-08-13 KR KR1020017001970A patent/KR100710533B1/ko not_active Expired - Lifetime
- 1999-08-13 EE EEP200100079A patent/EE04903B1/xx unknown
- 1999-08-13 ME MEP-2008-893A patent/ME00533B/me unknown
- 1999-08-13 SK SK230-2001A patent/SK285212B6/sk not_active IP Right Cessation
- 1999-08-13 JP JP2000564623A patent/JP5354762B2/ja not_active Expired - Lifetime
- 1999-08-13 CZ CZ2001604A patent/CZ293959B6/cs not_active IP Right Cessation
- 1999-08-13 NZ NZ509965A patent/NZ509965A/en not_active IP Right Cessation
- 1999-08-13 ID IDW20010379A patent/ID27545A/id unknown
- 1999-08-13 WO PCT/EP1999/006291 patent/WO2000009120A1/en not_active Ceased
- 1999-08-13 EP EP99944531A patent/EP1109547A1/en not_active Withdrawn
- 1999-08-13 HU HU0103748A patent/HU230235B1/hu unknown
- 1999-08-13 IL IL14123899A patent/IL141238A0/xx not_active IP Right Cessation
- 1999-08-13 CA CA002340921A patent/CA2340921C/en not_active Expired - Lifetime
2001
- 2001-02-07 NO NO20010654A patent/NO327296B1/no not_active IP Right Cessation
- 2001-02-16 BG BG105264A patent/BG65365B1/bg unknown

Also Published As

Publication number	Publication date
EP1109547A1 (en)	2001-06-27
ME00533B (me)	2011-10-10
YU7901A (sh)	2003-12-31
HUP0103748A3 (en)	2003-01-28
HU230235B1 (hu)	2015-10-28
EE200100079A (et)	2002-08-15
EE04903B1 (et)	2007-10-15
AU766168B2 (en)	2003-10-09
HUP0103748A2 (hu)	2002-04-29
NO327296B1 (no)	2009-06-02
SK2302001A3 (en)	2001-09-11
SK285212B6 (sk)	2006-09-07
NO20010654L (no)	2001-02-07
WO2000009120A1 (en)	2000-02-24
CA2340921C (en)	2009-01-06
BG65365B1 (bg)	2008-04-30
BG105264A (en)	2001-11-30
AU5741999A (en)	2000-03-06
CA2340921A1 (en)	2000-02-24
JP2002522490A (ja)	2002-07-23
US6346543B1 (en)	2002-02-12
NO20010654D0 (no)	2001-02-07
KR100710533B1 (ko)	2007-04-23
KR20010085396A (ko)	2001-09-07
TR200100557T2 (tr)	2001-07-23
CZ2001604A3 (en)	2001-06-13
IL141238A0 (en)	2002-03-10
CZ293959B6 (cs)	2004-08-18
WO2000009120A8 (en)	2001-04-05
JP5354762B2 (ja)	2013-11-27
NZ509965A (en)	2003-09-26
RS52011B (sr)	2012-04-30

Publication	Publication Date	Title
NO20010654D0 (no)	2001-02-07	Ny anvendelse av taxoidderivater
TR200201430T2 (tr)	2003-01-21	Antiproliferatif maddeler olarak faydalı yeni benzoimidazol türevleri.
DE69923849D1 (de)	2005-03-31	Quinolin-2-on-derivate verwendbar als antikrebsmittel
GEP20064005B (en)	2006-12-25	Use of novel benzoimidazole derivatives as antiproliferative agents
EA200201277A1 (ru)	2003-06-26	Замещенные бициклические производные для лечения аномального роста клеток
ES2115163T3 (es)	1998-06-16	Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
RU94044436A (ru)	1996-10-20	Способы подавления атрофии кожи и влагалища
BG106104A (en)	2002-05-31	Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
RU94044490A (ru)	1996-10-20	Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани
MXPA05009303A (es)	2005-10-05	Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr.
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
PT1144365E (pt)	2004-06-30	Inibidores da adesao de celulas mediada por alfa4beta1
ES2123873T3 (es)	1999-01-16	Pirrolocarbazol.
RU94037246A (ru)	1996-11-10	Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща
MY121046A (en)	2005-12-30	Substituted bisindolylmaleimides for the inhibition of cell proliferation
ES2091249T3 (es)	1996-11-01	Analogos de iludina utilizables como agentes antitumorales.
RU94045271A (ru)	1996-10-10	Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
NO20014240D0 (no)	2001-08-31	C16-umettede FP-selektive prostaglandinanaloger
EP1109560A4 (en)	2002-04-17	COMPOUNDS USEFUL AS AICARFT INHIBITORS
TR199900153T2 (xx)	1999-04-21	H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
NZ511559A (en)	2004-01-30	Use of staurosporine derivatives for treating ocular neovascular diseases
MXPA02004702A (es)	2004-09-10	Analogos interrumpidos por heteroatomos de acido 15-hidroxieicosatetraenoico y metodos de uso.
MX9701333A (es)	1997-05-31	Metodos para inhibir el daño neuronal.
FR2392966A1 (fr)	1978-12-29	Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
IL136225A0 (en)	2001-05-20	Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation